In our study, we chose to test whether VKNG-1 could act as a chemosensitizing agent to the ABCG2-overexpressing MDR phenotype of cancer cells and explore the mechanism of ABCG2-mediated chemoresistance. This evidence concerns the gene ABCG2 and cancer.